| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.4 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |